1933 Industries Reports First Quarter 2022 Financial Results

Rhea-AI Summary

1933 Industries (CSE:TGIF)(OTCQB:TGIFF) reported its Q1 2022 financial results, revealing total revenues of $2.5 million, down from $2.7 million year-over-year. However, the company achieved significant improvements: net loss was reduced by 66% to $948,825, while operating expenses fell by 45%. Gross margins improved to 45% from 27%, and adjusted EBITDA loss improved by 78%. Cash balance was $3.2 million at the reporting date. Despite an overall decline in Nevada's cannabis sales, the company remains focused on strategic adjustments to enhance growth.

Positive

• Operating expenses reduced by 45%
• Gross margins improved by 18% to 45%
• Net loss decreased by 66% from $2.8 million to $948,825
• Adjusted EBITDA loss improved by 78% from $1.4 million to $303,978
• Cash balance increased to $3.2 million

Negative

• Total revenues declined by 8% year-over-year
• Working capital surplus decreased by 58% to $3.5 million

VANCOUVER, BC / ACCESSWIRE / December 30, 2021 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCQB:TGIFF), a Nevada-focused cannabis consumer packaged goods company, is pleased to announce its first quarter ("Q1 2022") financial results for the three months ended October 31, 2021. All amounts expressed are in Canadian dollars.

Financial statements are prepared in accordance with International Financial Reporting Standards (IFRS). Detailed information regarding the Company's financial results as well as management's discussion and analysis can be found at https://sedar.com/ and https://1933industries.com/investors/financial-information

First Quarter Financial Highlights

• Reduced operating expenses by 45%
• Improved gross margins by 18%
• Reduced net loss by 66%
• Adjusted EBITDA loss improved by 78%

		Q1 2022 Financial Highlights
		October 31, 2021				October 31, 2020
Revenues		$	2,466,064			$	2,687,516
Gross margin		$	1,103,102			$	728,700
Expenses		$	1,937,229			$	3,544,687
Net loss for the period		$	(948,825	)		$	(2,818,577	)
Basic and diluted loss per share		$	(0.00	)		$	(0.01	)
Comprehensive loss for the period		$	(1,120,750	)		$	(2,929,123	)
Adjusted EBITDA loss		$	(303,978	)		$	(1,351,212	)
Cash balance		$	3,162,952			$	2,044,573
Total assets		$	44,585,701			$	45,431,525
Total liabilities		$	20,418,844			$	26,714,275
Total liabilities and shareholders' equity		$	44,585,701			$	45,431,525

Q1 2022 CONSOLIDATED OPERATING FINANCIAL HIGHLIGHTS

• Total revenues were $2.5 million for Q1 2022 and $2.7 million for Q1 2021.
• Expenses were $1.9 million for Q1 2022 compared to $3.5 million for Q1 2021, a decrease of 45%.
• Gross margin was $1.1 million or 45% for Q1 2022 and $0.7 million or 27% for Q1 2021.
• Net loss from continuing operations was $0.9 million for Q1 2022 compared to a net loss of $2.8 million for Q1 2021, an improvement of 66%.
• Adjusted EBITDA loss was $0.3 million for Q1 2022 compared to adjusted EBITDA loss of $1.4 million for Q1 2021, an improvement of 78%.

Q1 2022 CONSOLIDATED BALANCE SHEET FINANCIAL HIGHLIGHTS

• Cash at October 31, 2021 was $3.2 million, compared to $4.4 million at July 31, 2021, a decrease of 27%.
• Total assets at October 31, 2021 were $44.6 million, compared to $45.4 million at July 31, 2021.
• Working capital at October 31, 2021 was a surplus of $3.5 million, compared to working capital surplus of $8.4 million at July 31, 2021, a decrease of 58%. The decrease was due to the reclassification of $4.3 million convertible debentures to from long-term to current liabilities.

Management Commentary by Mr. Paul Rosen, Chairman and CEO of 1933 Industries

Over Q1 2022, the Company continued to make strategic cost reductions across all divisions, with the goal of achieving consistent profitability. The Company successfully extended its convertible debt to mature in September 2022, reduced operating expenses by 45%, improved gross margins by 18%, and reduced net loss by 66% compared to Q1 2021.

Although Nevada's legal cannabis industry surpassed $1 billion in taxable sales in fiscal 2021, sales in the state during the reporting quarter declined. According to BDSA data, in September and October 2021, Nevada sales were down 8.4% from August and down 11% from the year prior. Cannabis flower sales fell 25% from the previous year. The Company believes that softening sales were due to changing employment patterns in Nevada, a resurgence of Covid-19 and corresponding social distancing and mask mandates, and the increase of low-priced flower flooding the market. As a result, AMA sales remained flat during the reporting quarter. To combat and rectify these issues, the Company has readjusted its pricing strategy to meet market demands, continues to increase shelf space with sought-after flower strains and in-demand infused pre-rolls, and recruited and installed an improved leadership team covering sales and cultivation under the direction of Ms. Ester Vigil and Mr. Steve Licon, both leading professionals in the Nevada cannabis market. The Company believes that the changes it has made in both its cultivation and post-harvest processes and procedures will result in increased flower capacity, consistency, and quality and that the Company remains on the right path to improve its growth and reach consistent profitability in fiscal 2022 and beyond.

Q1 2022 Key Developments

Refer to Management Discussions and Analysis

Please note the next financial release dates in accordance with the continuous disclosure schedule set out by the British Columbia Securities Commission:

Q2/2022: April 1, 2022
Q3/2022: June 29, 2022
Q4/YE 2022: November 28, 2022

About 1933 Industries Inc.

1933 Industries is a Nevada-based, growth-orientated company, focusing on the cultivation and manufacturing of a large portfolio of cannabis consumer-packaged goods in a variety of formats for both the wholesale and retail markets. Its product offerings include: THC flower, pre-rolls, and extracted products under the AMA and Level X brands for the Nevada market; and national cannabidiol (CBD) brand of infused wellness products including CBD tinctures, gummies, topicals and sport recovery products. The Company owns 91% of Alternative Medicine Association, LC (AMA), and 100% of Infused MFG LLC. www.1933industries.com

About Alternative Medicine Association

AMA is a licensed medical and adult-use cannabis cultivation and extraction subsidiary that produces its own branded line of unique cannabis products. AMA's extensive menu of cannabis products include: craft cannabis flower, pre-rolls, full spectrum oils, high quality distillates, proprietary blends of terpenes, vaporizer products and boutique concentrates such as shatter, crumble, batter, sugar wax, diamonds, and live resin. Ultra-craft brand Level X is an exclusive collection of exotic strains, selected specifically for their distinctive terpene profiles, high THC levels, and flavonoids With state-of-the-art cultivation and extraction facilities based in Las Vegas, Nevada, AMA seeks to offer medical patients and recreational users alike a cannabis experience that's exceptional, potent, and consistent in quality. www.amanev.com

AMA is also licensed in Nevada as an adult-use cannabis distributor.

About Canna Hemp™

With an extensive product line that includes CBD topicals, CBD creams, CBD gummies, CBD vaporizers, CBD tinctures, CBD capsules, CBD pre and post workout recovery sports products, and CBG and CBN tinctures, 1933 Industries' proprietary Canna Hemp™ brand utilizes the power of hemp-extracted cannabinoids to bring natural wellness.

For further information please contact:
Alexia Helgason, VP, IR and Corporate Communications
604-674-4756 (ext. 1)
alexia@1933industries.com

Paul Rosen, CEO
604-674-4756 (ext. 1)

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Notice regarding Forward Looking Statements: This news release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents, which can be found under the Company's profile on www.sedar.com. 1933 Industries undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.

SOURCE: 1933 Industries Inc.

View source version on accesswire.com:
https://www.accesswire.com/680295/1933-Industries-Reports-First-Quarter-2022Financial-Results

FAQ

What were the Q1 2022 financial results for 1933 Industries (TGIFF)?

In Q1 2022, 1933 Industries reported revenues of $2.5 million, a net loss of $948,825, and improved gross margins of 45%.

How much did 1933 Industries reduce its operating expenses in Q1 2022?

The company reduced its operating expenses by 45% compared to the same quarter last year.

What was the cash balance reported by 1933 Industries at the end of Q1 2022?

The cash balance at the end of Q1 2022 was $3.2 million.

How did 1933 Industries perform in terms of net loss in Q1 2022?

The net loss for Q1 2022 was reduced by 66%, amounting to $948,825.

What challenges did 1933 Industries face in the Nevada cannabis market?

The company faced a decline in overall cannabis sales in Nevada, with flower sales down by 25% compared to the previous year.